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1. Introduction
  In malignant tumors, lung cancer incidence and mortality are at 
the forefront, and its occurrence and development are a complicated 
process related with many signal pathways. With environmental 
deterioration, lung cancer incidence and mortality are increasing 
year by year. In many classifications of lung cancers, non-small 
cell lung cancer (NSCLC) accounts for about above 80%, and it is 
difficult to diagnose early, so most of NSCLC are diagnosed at late 
stages. It is very important and urgent that treatment strategies are 
determined for effective treatment.  
  MicroRNAs are a class of highly conservative microRAN 
segments with length of about 22 nucleotide fragments, and regulate 
gene expressions mainly by binding with target gene mRNA 
3’UTR at post-transcriptional level[1], and then participates in 
cell proliferation, apoptosis, differentiation, senescence and other 
physiological progresses. Abnormal expression of microRNA is 
closely related with occurrence and development of many tumors. 
  MicroRNA-126 is localized at 9q34.3 zone, and maintained high 
expression in lungs, hearts and kidneys of adults[2]. During lung 
development process in human and mouse lung, expression level of 
microRNA-126 showed time dependent, microRNA-126 expression 
gradually increases during lung development and maintains high 
expression level when lung matures. In addition, microRNA-
126 is also closely related with occurrence and development of 
tumors. Tavazoie et al have found that microRNA-126 could inhibit 
mammary cancer proliferation and metastasis, and play the roles of 
tumor suppressor genes[3]. Musiyenko et al found that microRNA-
126 could inhibit colon cancer cell proliferation by inhibiting 
PI3K signal transduction pathway[4]. In addition, microRNA-126 
expression level is also closely related with five-year survival rate of 
NSCLC patients[5]. Gene chip results indicated that microRNA-126 
expression level was significantly decreased in lung cancer patients 
compared with peficancerous tissues.
2. Materials and methods 
2.1.Materials 
  VEGF overexpression plasmid and control plasmid, Vegf-3’ UTR 
luci were constructed by GeneChem (GeneChem, China) Company; 
Vegf-3’ UTR luci microRNA-126 binding site mutation was 
finished by TransGen (TransGen, China) Company.
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Both microRNA-126 reverse transcription primers and qRT-PCR 
primers were bought from RiboBio Company, and operations were 
strictly followed by product instructions. 
  Anti-VEGF(sc-7269) was bought from Santa Cruz, and secondary 
antibody was bought from Beijing Zhongshan Biotechnology 
Company.
2.2. Small segments of microRNA-126 expression 
  Both Scramble and Mimics of microRNA-126 were bought from 
RiboBio (RiboBio, China) Company. Mimics are chemically 
synthesized segments, and have the same sequences as microRNA-
126, and they are transfected to the cells to enhance endogenous 
microRNA-126 functions; Scramble is a segment with random 
arrangement of 22 nucleotides. 
2.3. MicroRNA extraction 
  Small molecule RNA (≤200 nt) was extracted from the cell line 
by mir Vana™ miRNA Isolation extraction kit strictly according to 
product instructions. 
2.4. CCK-8 assay, EdU assay and Luciferase report assay
  Cell Counting Kit-8 (CCK-8) was bought from Dojindo 
Laboratories, Kumamoto, Japan, and operations were strictly 
followed by product instructions. EdU cell proliferation test kit was 
bought from RiboBio (RiboBio, China) Company, and operations 
were strictly followed by product instructions. Luciferase dual report 
system kit was bought from Vigorous Company, and luciferase 
activity was detected according to the kit instructions.
2.5. Statistics analysis 
  Each experiment was repeated at least three times, and the data 
were represented by mean 暲SD, and the results were analyzed by 
SPSS statistics software One-Way ANOVA or student-t test; P<0.05 
represented significant difference. 
3. Results
3.1. Inhibitive effect of microRNA-126 overexpression on the 
proliferation of A549 cells
  To investigate the roles of microRNA-126 in lung cancer 
occurrence and development, A549 cells, a human lung cancer cell 
line was selected. Small segment mimics of microRNA-126 were 
transfected into A549 cells, and detected by qRT-PCR. The result 
showed that the overexpression efficiency was very significant 
(Figure 1). CCK-8 experiment and EdU experiment are commonly 
methods used for detecting cell proliferation ability. CCK-8 
experiment showed that cell proliferation ability of microRNA-126 
overexpression group was significantly decreased compared with 
that of Scramble-transfected control group in 24 h and 48 h (Figure 
2). EdU experiment results also showed that positive rate of EdU in 
microRNA-126 overexpression group was significantly decreased 
compared with control group (Figure 3). Consequently, microRNA-
126 could inhibit A549 cells proliferation.
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Figure 1. Expression level of miR-126 by qRT-PCR assay. 
*, P<0.05 compared with the control.
5.0
4.0
3.0
2.0
1.0
0
C
el
l g
ro
w
th
 r
at
e 
(f
ol
d)
con                             Scramble                           Mimics
0 h                  24 h                48 h
 
Figure 2. Cell growth rate by CCK-8 assay.
*, P<0.05 compared with the control.
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Figure 3. EdU incorporation rate by EdU assay. 
*, P<0.05 compared with the control.
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3.2. Vegf was a target gene of microRNA-126 
  Three authoritative miRNAs target genes-predicting databases were 
employed: miRanda, TargetScan, microRNA. org, and potential 
target genes of microRNA-126 in three informatics websites were 
gathered, and GO cluster analysis was processed using “proliferation” 
as a keyword. We found that Vegf was a target gene with the highest 
score, and bioinformatics analysis showed that 3’UTR region of 
Vegf gene mRNA had microRNA-126 binding sites, inidicating that 
Vegf might be a target gene of microRNA-126 (Figure 4). Western 
blot assay results showed that VEGF protein expression level was 
downregulated when microRNA-126 was overexpressed in A549 
cells (Figure 5).
 
Figure 4. Posotion 1212-1232 of Vegf 3’UTR.
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Figure 5. Protein expression level by Western blot assay.
  Vegf-3’UTR segment was inserted into luciferase reporter plasmid 
to construct Vegf-3’ UTR luci plasmid and then the plasmid was 
transfected to cells together with microRNA-126Mimics. It was 
found that overexpression of microRNA-126 decreased luciferase 
activity compared with control group. When binding site binding 
with microRNA-126 was mutated on Vegf-3’UTR luci plasmid 
(ACGGUAC->ACGGUGU), overexpression of microRNA-126 
could not lead to decrease of luciferase activity again (Figure 6). 
The experiment above could determine that Vegf is a target gene of 
microRNA-126.
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Figure 6. Luciferase activity by luciferase reporter assay. 
*, P<0.05 compared with the control.
3.3.Reverse effect of VEGF on proliferation and migration-
promoting effect of microRNA-126 
  VEGF overexpression plasmid was successfully constructed (Figure 
7). MicroRNA-126 Mimics and VEGF overexpression plasmid 
(VEGF OE) were co-transfected to A549 cells, and compared with 
empty vector, microRNA-126-induced cell proliferation effect was 
reversed (Figure 8, 9). 
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Figure 7. Effect of VEGF overexpression in A549 cells.
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Figure 8. Cell growth rate bu CCK-8 assay.y
*, P<0.05 compared with the control.
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Figure 9. EdU incorporation rate by EdU assay. 
*, P<0.05 compared with the control.
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4. Discussion
  Until now, studies on microRNA-126 mainly focuse on aspects of 
effects that it was a tumor suppressor gene[8]. In recent years, the 
roles of microRNA-126 in inflammation aspects also attract people’s 
attention, but its detailed mechanism is still not clear[9]. In addition, 
in development process of human lung, heart and kidney, the roles of 
microRNA-126 also need further investigation. 
  At present, people’s attention focuses on the functions of microRNA 
in tumor occurrence and development, but molecular mechanisms 
how microRNAs playing their roles are still not understood, and 
there are many conceptive and experimental problems. Up to 
2014, Sanger miRBase database (miRBase 21 released) has 28645 
approved microRNAs, in which only dozens of microRNAs have 
been analyzed in lung cancer occurrence and development up to 
now. It’s a new arduous task to seek other lung cancer-associated 
microRNAs, identify its downstream target molecule and determine 
the mechanisms of microRNAs playing roles in lung cancer 
occurrence and development.
Conflict of interest statement
  We declare that we have no conflict of interest.
References 
[1]   Wang J, Jia Z, Zhang C, Sun M, Wang W, Chen P, et al. miR-499 protects 
cardiomyocytes from H2O2-induced apoptosis via its effects on Pdcd4 
and Pacs2. RNA Biol 2014; 11: 339-350.
[2]   Fitch MJ, Campagnolo L, Kuhnert F, Stuhlmann H. Egfl7, a novel 
epidermal growth factor-domain gene expressed in endothelial cells. Dev 
Dyn 2004; 230: 316-324.
[3]   Kraus B, Monk B, Sliva K, Schnierle BS. Expression of human 
endogenous retrovirus-K coincides with that of micro-RNA-663 and -638 
in germ-cell tumor cells. Anticancer Res 2012; 32: 4797-4804.
[4]   Musiyenko A, Bitko V, Barik S. Ectopic expression of miR-126*, an 
intronic product of the vascular endothelial EGF-like 7 gene, regulates 
prostein translation and invasiveness of prostate cancer LNCaP cells. J 
Mol Med (Berl) 2008; 86: 313-322.
[5]   Crawford M, Brawner E, Batte K, Yu L, Hunter MG, Otterson GA, et al. 
MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell 
lines. Biochem Biophys Res Commun 2008; 373: 607-612.
[6]   Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ. 
MicroRNA-126 regulates endothelial expression of vascular cell adhesion 
molecule 1. Proc Natl Acad Sci U S A 2008; 105: 1516-1521.
[7]   Chen YH, Pan SL, Wang JC, Kuo SH, Cheng JC, Teng CM. Radiation-
induced VEGF-C expression and endothelial cell proliferation in lung 
cancer. Strahlenther Onkol 2014; 190: 1154-1162.
[8]   Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, et al. Aberrant 
expression of oncogenic and tumor-suppressive microRNAs in cervical 
cancer is required for cancer cell growth. PLoS One 2008; 3: e2557.
[9]   Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, Yuasa Y. 
MicroRNA-126 inhibits SOX2 expression and contributes to gastric 
carcinogenesis. PLoS One 2011; 6: e16617.
Document heading          doi: 10.1016/S1995-7645(14)60324-2 
Afebrile presentation of 2014 Western Africa Ebolavirus infection: the 
thing that should not be forgotten
Beuy Joob1*, Viroj Wiwanitkit2,3,4,5 
1Medical Academic Center, Bangkok Thailand
2Hainan Medical University, China
3Faculty of Medicine, University of Nis, Serbia
4Joseph Ayobabalola University, Nigeria
5Dr DY Patil Medical University, India
  *Corresponding author: BeuyJoob, Medical Academic Center, Bangkok Thailand.
    E-mail: beuyjoob@hotmail.com
  The 2014 Western Ebolavirus infectionis the serious emerging 
disease at present[1-3]. This disease result in high fatality and 
rapidly widespread in Africa, hence, it becomes the present concern 
for medical society[1-3]. The knowledge on clinical presentation 
on this new Ebola virus infection is extremely limited. It is known 
only that Ebola virus infection can present as an acute febrile illness 
with hemorrhagic complication. Here, the authors try to summarize 
on the magnitude of “fever” as presentation in the 2014 Western 
Ebolavirus infection. Based on available data from 15 confirmed 
casesreported from Guinea[1-4], not all cases showed fever at 
presentation. The rate of afebrile case at presentation is equal to 
9.3%. Hence, it should be noted that the afebrile 014 Western 
Ebolavirus infection is possible and this challenge the immigration 
system that mainly use fever screening as tool for screening traveler 
from outbreak area.
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